000 01199 a2200361 4500
005 20250513173055.0
264 0 _c19920827
008 199208s 0 0 eng d
022 _a0267-6591
024 7 _a10.1177/026765919000500103
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aTamari, Y
245 0 0 _aCurrent priming solutions for cardiopulmonary bypass contain a potent coronary vasodilator.
_h[electronic resource]
260 _bPerfusion
_c1990
300 _a9-21 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAcetates
_xpharmacology
650 0 4 _aAnimals
650 0 4 _aCardioplegic Solutions
_xchemistry
650 0 4 _aCardiopulmonary Bypass
650 0 4 _aCoronary Circulation
_xdrug effects
650 0 4 _aCoronary Vessels
_xdrug effects
650 0 4 _aDogs
650 0 4 _aMyocardium
_xmetabolism
650 0 4 _aOxygen Consumption
650 0 4 _aVascular Resistance
_xdrug effects
650 0 4 _aVasodilation
700 1 _aTortolani, J A
700 1 _aMaguine, M
700 1 _aCzegledy, F
773 0 _tPerfusion
_gvol. 5
_gno. 1
_gp. 9-21
856 4 0 _uhttps://doi.org/10.1177/026765919000500103
_zAvailable from publisher's website
999 _c10109013
_d10109013